The Prevalence Evaluation of Systemic Lupus Erythematosus in Russian Patients with Reproductive issues (PRISMA)

Trial Identifier: D3461R00069
Sponsor: AstraZeneca
Start Date: September 2023
Primary Completion Date: June 2024
Study Completion Date: June 2024
Condition: Lupus

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Russia Kazan, Russia
Russia Moscow, Russia
Russia Nizhniy Novgorod, Russia
Russia Novosibirsk, Russia
Russia Orenburg, Russia
Russia Rostov on Don, Russia
Russia Saint Petersburg, Russia
Russia Ufa, Russia
Russia Voronezh, Russia